Inventis Advances with $5.7M Orders and $2.5M US Capital Raise in Q2

Inventis Limited reported robust Q2 progress with over $5.7 million in confirmed orders and a $2.5 million capital raise underway in the US, signaling strong momentum in its technology-driven growth strategy.

  • Confirmed Opentec orders exceeding $5.7 million for Q2
  • US Hazavoid Tx LLC pursuing $2.5 million capital raise
  • New partnership for emergency vehicle sales in the Philippines
  • Technology sales surged 267% in December despite YTD decline
  • Cost reductions of $1.375 million achieved with further savings planned
An image related to Unknown
Image source middle. ©

Q2 Highlights and Order Book Strength

Inventis Limited (ASX: IVT) has delivered a quarter marked by significant contract wins and strategic capital initiatives. The company confirmed Opentec orders exceeding $5.7 million in Q2, with settlements expected in Q3 2025. This underpins a solid revenue pipeline amid a broader push to expand its technology footprint internationally.

Alongside these orders, Inventis is actively marketing a $2.5 million USD capital raise for its US-based Hazavoid Tx LLC entity. This initiative aims to fuel growth in the high-potential US market, where Hazavoid has already secured sales and developed a qualified pipeline of client quotes exceeding AUD$3.4 million.

Strategic Partnerships and Market Expansion

The company’s international ambitions are further evidenced by a new exclusive agency agreement with the Varley Group in the Philippines. This partnership enables Inventis to sell custom emergency vehicles, including fire trucks and ambulances, targeting a market potentially worth over $60 million. The Philippines government’s Local Government Units (LGUs) are also a key focus, with confirmed orders and ongoing efforts to integrate Hazavoid solutions into national risk management frameworks.

In the US, Hazavoid has upgraded its mass notification system to align with the K-12 Standard Response Protocol, positioning itself as the only national wireless brand offering this custom solution. The planned launch of a Hazavoid mobile app with a subscription revenue model could generate up to $4 million annually by 2029, reflecting a strategic shift towards recurring income streams.

Operational Performance and Cost Management

Despite a 30% year-to-date decline in technology sales due to timing of large orders, December sales surged 267% compared to last year, indicating a strong rebound. The company continues to align costs with income, achieving $1.375 million in employment cost reductions over FY24 and FY25, with further savings planned through natural attrition and overhead efficiencies.

Inventis also reported high delivery performance, with on-time and in-full delivery KPIs ranging from 92.9% to 100% across divisions, underscoring operational discipline amid growth initiatives.

Capital Management and Funding Outlook

Capital management remains a priority, with the board exploring multiple funding avenues including equity placements, convertible notes, and partnerships with venture and growth funds. The recent AGM approved a share sale of 49% equity in Electronic Circuit Designs (ECD), with a superior offer now under consideration that could unlock approximately $3 million and reduce $1.5 million in loans.

Inventis holds approximately $7 million in unused financing facilities, providing a buffer for ongoing operations and growth investments. The company’s leadership expresses confidence that these measures will support the ambitious international expansion and technology transformation plans underway.

Looking Ahead

Inventis is positioning itself as a technology-driven group with a growing global footprint, particularly in emergency management solutions. While sales are currently impacted by order timing, the company anticipates a correction in the second half of FY25, supported by a robust pipeline and new product developments. The unfolding capital raises and strategic partnerships will be critical to sustaining momentum and unlocking the full potential of its diverse business units.

Bottom Line?

Inventis’ Q2 progress sets the stage for a pivotal year of growth, but execution of capital raises and order conversions will be key to sustaining its upward trajectory.

Questions in the middle?

  • Will the $2.5 million US capital raise for Hazavoid Tx LLC close successfully and on what terms?
  • How quickly can Inventis convert its strong pipeline into confirmed orders in Q3 and Q4?
  • What impact will the new emergency vehicle partnership in the Philippines have on revenue and margins?